de toekomstperspectieven geschetst als
op de Journées internationales de la So-
ciété Française de Neurologie 2013 (24):
nieuwe researchcriteria met inclusie van
biomarkers in het CSV, en structurele,
metabole en amyloïdscanning, waarmee
de diagnose van ziekte van Alzheimer in
een prodromaal stadium kan worden
gesteld, voor ze enige weerslag heeft op
de autonomie. De therapeutische studies
bij de ziekte van Alzheimer hebben over
het algemeen negatieve uitkomsten ge-
geven. Alle hoop wordt nu gesteld in de
studies die lopen bij patiënten met de
ziekte van Alzheimer in een prodromaal
en dus een vroeg stadium, ook al is het
methodologisch erg complex om derge-
lijke studies uit te voeren.
het volgende congres van de WCN,
hoofdstad Santiago.
1.
mental deterioration in the elderly. Lancet
1974;2:207-9.
Learning. Oxford University Press, Londres, 1961.
Paris, 2006.
Brain Stimulation in advanced Parkinson disease.
Ann Neurol. 2013;74(3):449-57.
independent and location-linked representations of
sound objects. Neuroimage 2013;73:40-9.
evidence from neuroimaging and neurostimulation.
Neuropsychol Rehabil 2011;21(5):742-54.
training and brain stimulation in chronic aphasia.
Neuropsychol Rehabilitation;21(5):717-41.
of circuit training as alternative to usual
physiotherapy after stroke: randomized controlled
trial. BMJ 2012;344:e2672.
DaTscan SPECT imaging on clinical management,
diagnosis, confidence of diagnosis, quality of live,
health resource use and safety in patients with
clinically uncertain parkinsonian syndromes: a
prospective 1-year follow-up of an open-label
controlled study. Journal of neurology neurosurgery
and psychiatry 2012;83:620-8.
diagnosis of dementia due to Alzheimer's disease:
Recommendations from the National Institute on
Aging-Alzheimer's Association workgroups on
diagnostic guidelines for Alzheimer disease.
Alzheimer's Dement 2011;7(3):263-9.
criteria for the diagnosis of Alzheimer's disease:
revising the NINCDS-ADRDA criteria. The lancet
Neurology 2007;6(8):734-46.
defining the preclinical stages of Alzheimer's
disease: recommendations from the National
Institute on Aging-Alzheimer's Association
workgroups on diagnostic guidelines for Alzheimer's
disease. Alzheimers Dement 2011;7(3):280-92.
Alzheimer-related changes. Acta Neuropathol
1991;82:239-59.
validation of a cued recall memory deficit in
prodromal Alzheimer disease. Neurology
2012;78(6):379-86.
biomarkers and incipient Alzheimer disease in
patients with mild cognitive impairment. JAMA,
2009;302(4):385-93.
18F-flutemetamol amyloid imaging in Alzheimer
disease and mild cognitive impairment: a phase 2
trial. Ann Neurol 2010; 68(3):319-29.
AV-45) PET to assess amyloid burden in Alzheimer's
disease dementia, mild cognitive impairment and
normal aging. Alzheimers Dement
2013;9(0):S72-S83.
al. The Challenges of Tau Imaging. Future Neurology
2012; 7(4):409-421.
selective and specific PET tracer for imaging of tau
pathologies. J Alzheimers Dis. 2012 ;31(3):601-12.
challenge. Funct Neurol 2013;28(3):167-73.
Assessment of system dysfunction in the brain
through MRI-based connectomics. Lancet Neurol
2013;12(12):1189-99.
thrombectomy after failure of intravenous
thrombolysis in acute ischemic stroke: preliminary
results of a multicenter prospective observational
study. Poster 361/Session 2; WCN 2013, Vienne.
met anti-NMDA-receptorantilichaam positieve
encephalitis op basis van een matuur teratoom in het
mediastinum. Neurone 2013;18(9):47-51.
nouveaux concepts, nouveaux enjeux. Revue
Neurologique 2013;169(10):677-833.